Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$4.77 - $9.16 $609,749 - $1.17 Million
-127,830 Reduced 67.21%
62,355 $297,000
Q4 2022

Feb 14, 2023

BUY
$8.17 - $12.95 $97,231 - $154,117
11,901 Added 6.68%
190,185 $1.65 Million
Q3 2022

Nov 14, 2022

SELL
$11.4 - $17.18 $58,789 - $88,597
-5,157 Reduced 2.81%
178,284 $2.12 Million
Q2 2022

Aug 12, 2022

BUY
$9.23 - $22.43 $124,208 - $301,840
13,457 Added 7.92%
183,441 $2.61 Million
Q1 2022

May 16, 2022

SELL
$14.86 - $23.55 $192,199 - $304,595
-12,934 Reduced 7.07%
169,984 $3.54 Million
Q4 2021

Feb 14, 2022

SELL
$19.99 - $30.24 $64,847 - $98,098
-3,244 Reduced 1.74%
182,918 $4.23 Million
Q3 2021

Nov 15, 2021

SELL
$26.84 - $36.58 $146,949 - $200,275
-5,475 Reduced 2.86%
186,162 $5.55 Million
Q2 2021

Aug 16, 2021

SELL
$28.01 - $36.01 $58,568 - $75,296
-2,091 Reduced 1.08%
191,637 $6.55 Million
Q1 2021

May 14, 2021

SELL
$30.66 - $49.5 $33,634 - $54,301
-1,097 Reduced 0.56%
193,728 $6.37 Million
Q4 2020

Mar 01, 2021

SELL
$31.86 - $61.51 $4.94 Million - $9.54 Million
-155,175 Reduced 44.34%
194,825 $12 Million
Q3 2020

Nov 13, 2020

BUY
$35.5 - $38.0 $12.4 Million - $13.3 Million
350,000 New
350,000 $12.4 Million

Others Institutions Holding PMVP

About PMV Pharmaceuticals, Inc.


  • Ticker PMVP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,622,600
  • Market Cap $73.5M
  • Description
  • PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...
More about PMVP
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.